A phase II study of MDX-010 in patients with stage IV adenocarcinoma of the breast.
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2012
At a glance
- Drugs Ipilimumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 Apr 2012 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 Company (Bristol-Myers Squibb) added as as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.